A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis.
Beswick E, Park E, Wong C, Mehta AR, Dakin R, Chandran S, Newton J, Carson A, Abrahams S, Pal S.
Beswick E, et al.
J Neurol. 2021 Dec;268(12):4510-4521. doi: 10.1007/s00415-020-10203-z. Epub 2020 Sep 10.
J Neurol. 2021.
PMID: 32910255
Free PMC article.
Review.
BACKGROUND: Up to 50% of people with amyotrophic lateral sclerosis (ALS) experience cognitive dysfunction, whilst depression and anxiety are reported in up to 44% and 33%, respectively. ...RESULTS: 216 trials, investigating 26,326 people with ALS, were review …
BACKGROUND: Up to 50% of people with amyotrophic lateral sclerosis (ALS) experience cognitive dysfunction, whilst depre …